Skin damage after the hematopoietic stem cell transplantation. Literature review
- Authors: Aliev T.Z.1, Machneva E.B.1,2, Sidorova N.V.1, Belysheva T.S.1, Valiev T.T.1, Kirgizov K.I.1
- 
							Affiliations: 
							- N.N. Blokhin National Medical Research Center of Oncology, Ministry of Healthcare of Russian Federation
- Russian Children’s Clinical Hospital of the N.I. Pirogov Russian National Research Medical University, Ministry of Healthcare of Russian Federation
 
- Issue: Vol 19, No 2 (2020)
- Pages: 184-192
- Section: LITERATURE REVIEW
- Submitted: 02.07.2020
- Accepted: 02.07.2020
- Published: 02.07.2020
- URL: https://hemoncim.com/jour/article/view/355
- DOI: https://doi.org/10.24287/1726-1708-2020-19-2-184-192
- ID: 355
Cite item
Full Text
Abstract
Skin damage after hematopoietic stem cell transplantation (HSCT) is common and important diagnostic and therapeutic problem. The most significant causes of skin lesions in HSCT are drug toxicity, infections, and manifestations of skin acute and chronic “graft versus host” disease. Each of the complications can manifest in various forms, as well as to combine with others, exerting a significant negative effect on the patient’s condition, in severe cases posing a threat to the patient’s life. The article summarizes data on the etiology, features of pathogenesis, clinical forms, the main methods of diagnosis and therapy of the most common skin complications of HSCT.
About the authors
T. Z. Aliev
N.N. Blokhin National Medical Research Center of Oncology, Ministry of Healthcare of Russian Federation
							Author for correspondence.
							Email: timaliev118@gmail.com
				                	ORCID iD: 0000-0003-1091-1521
				                																			                								
Pediatric Oncologist Department of Pediatric Bone Marrow and Hematopoietic Stem Cell Transplantation of the Research Institute of Pediatric Oncology and Hematology,
Russia, 115478, Moscow, Kashirskoe Shosse, 23
Russian FederationE. B. Machneva
N.N. Blokhin National Medical Research Center of Oncology, Ministry of Healthcare of Russian Federation; Russian Children’s Clinical Hospital of the N.I. Pirogov Russian National Research Medical University, Ministry of Healthcare of Russian Federation
																		                	ORCID iD: 0000-0003-2395-4045
				                																			                												                	Russian Federation													
N. V. Sidorova
N.N. Blokhin National Medical Research Center of Oncology, Ministry of Healthcare of Russian Federation
																		                	ORCID iD: 0000-0003-3797-5808
				                																			                												                	Russian Federation													
T. S. Belysheva
N.N. Blokhin National Medical Research Center of Oncology, Ministry of Healthcare of Russian Federation
																		                	ORCID iD: 0000-0001-5911-553X
				                																			                												                	Russian Federation													
T. T. Valiev
N.N. Blokhin National Medical Research Center of Oncology, Ministry of Healthcare of Russian Federation
																		                	ORCID iD: 0000-0002-1469-2365
				                																			                												                	Russian Federation													
K. I. Kirgizov
N.N. Blokhin National Medical Research Center of Oncology, Ministry of Healthcare of Russian Federation
																		                	ORCID iD: 0000-0002-2945-284X
				                																			                												                	Russian Federation													
References
Supplementary files
 
				
			 
					 
						 
									
 
  
  
  Email this article
			Email this article 

